Skip to Content
Upcoming Webinar

Targeted Treatments for Ultra-Rare Sarcomas

Date: July 31, 2025 | 2:00 PM
Date: Thursday, July 31, 2025
Time: 2:00 p.m. EST

Sarcomas are rare – but ultra-rare subtypes like malignant PEComa, tenosynovial giant cell tumor (TGCT), and epithelioid sarcoma present unique challenges in diagnosis, treatment planning, and toxicity management. When trial data is limited, real-world clinical strategies become essential.

In this focused session, Sasha Watson, PharmD, BCOP, will share targeted approaches to treating these uncommon malignancies—covering therapeutic options, adverse event (AE) management, and individualized care strategies when evidence is scarce and the stakes are high.

What You’ll Learn

  • Understand the incidence and clinical complexity of sarcomas, including ultra-rare subtypes.

  • Identify targeted treatment options for malignant PEComa, TGCT, and epithelioid sarcoma.

  • Manage adverse effects associated with these therapies in real-world practice.

  • Apply case-based strategies for navigating clinical uncertainty in rare cancer care.

 

For additional information or login assistance, reach out to NCODA’s Jonathan Rivera.